Zhejiang Haitai Pharmaceutical Technology Co., Ltd. announced that it will receive CNY 102,286,600 in a round of funding from returning investor Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) on August 20, 2018. The transaction will be completed in two tranches. The first tranche will be received for CNY 30,000,000, of which CNY 18,450,000 will be used to pay the unpaid portion of the original subscribed registered capital and the remaining CNY 11,150,000 will be the new registered capital. The company will receive CNY 48,450,000 as new registered capital and CNY 23,836,600 for capital reserve in the second tranche which will be completed before June 30, 2019. Post closing, the registered capital of the company will increase to CNY 80,000,000. The transaction has been approved in the 10th meeting of the 6th Board of Directors and the 6th meeting of the 6th Board of Supervisors.